Literature DB >> 30147994

Nanoparticles for CRISPR-Cas9 delivery.

Zachary Glass1, Yamin Li1, Qiaobing Xu2.   

Abstract

The DNA mutation that causes Duchenne muscular dystrophy in mice can be corrected, with minimal off-target effects, by gold nanoparticles carrying the CRISPR components.

Entities:  

Year:  2017        PMID: 30147994      PMCID: PMC6107070          DOI: 10.1038/s41551-017-0158-x

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN: 2157-846X            Impact factor:   25.671


  14 in total

Review 1.  Genome editing. The new frontier of genome engineering with CRISPR-Cas9.

Authors:  Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2014-11-28       Impact factor: 47.728

Review 2.  Delivery technologies for genome editing.

Authors:  Hao Yin; Kevin J Kauffman; Daniel G Anderson
Journal:  Nat Rev Drug Discov       Date:  2017-03-24       Impact factor: 84.694

3.  Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles.

Authors:  Ming Wang; John A Zuris; Fantao Meng; Holly Rees; Shuo Sun; Pu Deng; Yong Han; Xue Gao; Dimitra Pouli; Qi Wu; Irene Georgakoudi; David R Liu; Qiaobing Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

Review 4.  Development and applications of CRISPR-Cas9 for genome engineering.

Authors:  Patrick D Hsu; Eric S Lander; Feng Zhang
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

5.  Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy.

Authors:  Chengzu Long; Leonela Amoasii; Alex A Mireault; John R McAnally; Hui Li; Efrain Sanchez-Ortiz; Samadrita Bhattacharyya; John M Shelton; Rhonda Bassel-Duby; Eric N Olson
Journal:  Science       Date:  2015-12-31       Impact factor: 47.728

6.  In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.

Authors:  Christopher E Nelson; Chady H Hakim; David G Ousterout; Pratiksha I Thakore; Eirik A Moreb; Ruth M Castellanos Rivera; Sarina Madhavan; Xiufang Pan; F Ann Ran; Winston X Yan; Aravind Asokan; Feng Zhang; Dongsheng Duan; Charles A Gersbach
Journal:  Science       Date:  2015-12-31       Impact factor: 47.728

7.  Genome engineering using the CRISPR-Cas9 system.

Authors:  F Ann Ran; Patrick D Hsu; Jason Wright; Vineeta Agarwala; David A Scott; Feng Zhang
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

8.  Mitochondrial alterations and oxidative stress in an acute transient mouse model of muscle degeneration: implications for muscular dystrophy and related muscle pathologies.

Authors:  Renjini Ramadasan-Nair; Narayanappa Gayathri; Sudha Mishra; Balaraju Sunitha; Rajeswara Babu Mythri; Atchayaram Nalini; Yashwanth Subbannayya; Hindalahalli Chandregowda Harsha; Ullas Kolthur-Seetharam; Muchukunte Mukunda Srinivas Bharath
Journal:  J Biol Chem       Date:  2013-11-12       Impact factor: 5.157

9.  Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair.

Authors:  Kunwoo Lee; Michael Conboy; Hyo Min Park; Fuguo Jiang; Hyun Jin Kim; Mark A Dewitt; Vanessa A Mackley; Kevin Chang; Anirudh Rao; Colin Skinner; Tamanna Shobha; Melod Mehdipour; Hui Liu; Wen-Chin Huang; Freeman Lan; Nicolas L Bray; Song Li; Jacob E Corn; Kazunori Kataoka; Jennifer A Doudna; Irina Conboy; Niren Murthy
Journal:  Nat Biomed Eng       Date:  2017-10-02       Impact factor: 25.671

10.  Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes.

Authors:  Brett T Staahl; Madhurima Benekareddy; Claire Coulon-Bainier; Ashwin A Banfal; Stephen N Floor; Jennifer K Sabo; Cole Urnes; Gabriela Acevedo Munares; Anirvan Ghosh; Jennifer A Doudna
Journal:  Nat Biotechnol       Date:  2017-02-13       Impact factor: 54.908

View more
  19 in total

1.  Intracellular Delivery of His-Tagged Genome-Editing Proteins Enabled by Nitrilotriacetic Acid-Containing Lipidoid Nanoparticles.

Authors:  Yamin Li; Alice Chukun Li; Qiaobing Xu
Journal:  Adv Healthc Mater       Date:  2018-11-22       Impact factor: 9.933

2.  Protein and mRNA Delivery Enabled by Cholesteryl-Based Biodegradable Lipidoid Nanoparticles.

Authors:  Yamin Li; Rachel Jarvis; Kuixin Zhu; Zachary Glass; Roza Ogurlu; Peiyang Gao; Peixuan Li; Jinjin Chen; Yingjie Yu; Yongjie Yang; Qiaobing Xu
Journal:  Angew Chem Int Ed Engl       Date:  2020-06-15       Impact factor: 15.336

Review 3.  Toward the Cure of HIV-1 Infection: Lessons Learned and Yet to be Learned as New Strategies are Developed.

Authors:  Jeffrey M Jacobson; Kamel Khalili
Journal:  AIDS Rev       Date:  2018       Impact factor: 2.500

Review 4.  Enzymatic noncovalent synthesis of peptide assemblies generates multimolecular crowding in cells for biomedical applications.

Authors:  Meihui Yi; Weiyi Tan; Jiaqi Guo; Bing Xu
Journal:  Chem Commun (Camb)       Date:  2021-12-03       Impact factor: 6.222

Review 5.  Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?

Authors:  María Vallet-Regí; Ferdi Schüth; Daniel Lozano; Montserrat Colilla; Miguel Manzano
Journal:  Chem Soc Rev       Date:  2022-07-04       Impact factor: 60.615

6.  Fabrication and characterization of PLGA nanoparticles encapsulating large CRISPR-Cas9 plasmid.

Authors:  Ami Jo; Veronica M Ringel-Scaia; Dylan K McDaniel; Cassidy A Thomas; Rui Zhang; Judy S Riffle; Irving C Allen; Richey M Davis
Journal:  J Nanobiotechnology       Date:  2020-01-20       Impact factor: 10.435

Review 7.  Ex vivo cell-based CRISPR/Cas9 genome editing for therapeutic applications.

Authors:  Yamin Li; Zachary Glass; Mingqian Huang; Zheng-Yi Chen; Qiaobing Xu
Journal:  Biomaterials       Date:  2020-01-10       Impact factor: 12.479

8.  Efficient Peptide-Mediated In Vitro Delivery of Cas9 RNP.

Authors:  Oskar Gustafsson; Julia Rädler; Samantha Roudi; Tõnis Lehto; Mattias Hällbrink; Taavi Lehto; Dhanu Gupta; Samir El Andaloussi; Joel Z Nordin
Journal:  Pharmaceutics       Date:  2021-06-14       Impact factor: 6.321

Review 9.  Genome and base editing for genetic hearing loss.

Authors:  Philipp Niggemann; Bence György; Zheng-Yi Chen
Journal:  Hear Res       Date:  2020-04-05       Impact factor: 3.208

10.  In vivo targeted delivery of nucleic acids and CRISPR genome editors enabled by GSH-responsive silica nanoparticles.

Authors:  Yuyuan Wang; Pawan K Shahi; Xiuxiu Wang; Ruosen Xie; Yi Zhao; Min Wu; Seth Roge; Bikash R Pattnaik; Shaoqin Gong
Journal:  J Control Release       Date:  2021-06-23       Impact factor: 11.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.